

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 6.86431209 |
| 2 | NADH metabolic process (GO:0006734) | 6.04397695 |
| 3 | triglyceride catabolic process (GO:0019433) | 5.82688359 |
| 4 | transcytosis (GO:0045056) | 5.25627683 |
| 5 | acylglycerol catabolic process (GO:0046464) | 5.13788829 |
| 6 | neutral lipid catabolic process (GO:0046461) | 5.13788829 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.96758259 |
| 8 | diacylglycerol metabolic process (GO:0046339) | 4.70719481 |
| 9 | barbed-end actin filament capping (GO:0051016) | 4.54456151 |
| 10 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.25502479 |
| 11 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.25502479 |
| 12 | angiotensin maturation (GO:0002003) | 4.15019964 |
| 13 | lipid storage (GO:0019915) | 3.94378848 |
| 14 | ethanol oxidation (GO:0006069) | 3.79234513 |
| 15 | extracellular fibril organization (GO:0043206) | 3.67894377 |
| 16 | regulation of cholesterol storage (GO:0010885) | 3.59631969 |
| 17 | glycerolipid catabolic process (GO:0046503) | 3.52789880 |
| 18 | virion attachment to host cell (GO:0019062) | 3.50418000 |
| 19 | adhesion of symbiont to host cell (GO:0044650) | 3.50418000 |
| 20 | lipoprotein transport (GO:0042953) | 3.49150288 |
| 21 | triglyceride biosynthetic process (GO:0019432) | 3.48011139 |
| 22 | fibril organization (GO:0097435) | 3.43916536 |
| 23 | acylglycerol biosynthetic process (GO:0046463) | 3.40458564 |
| 24 | neutral lipid biosynthetic process (GO:0046460) | 3.40458564 |
| 25 | protein heterotrimerization (GO:0070208) | 3.37594214 |
| 26 | cellular response to cadmium ion (GO:0071276) | 3.36350682 |
| 27 | response to phenylpropanoid (GO:0080184) | 3.31965637 |
| 28 | cGMP-mediated signaling (GO:0019934) | 3.30901420 |
| 29 | keratan sulfate catabolic process (GO:0042340) | 3.27235045 |
| 30 | primary alcohol metabolic process (GO:0034308) | 3.26168180 |
| 31 | triglyceride metabolic process (GO:0006641) | 3.24959402 |
| 32 | white fat cell differentiation (GO:0050872) | 3.22209880 |
| 33 | polyol transport (GO:0015791) | 3.21551388 |
| 34 | response to dietary excess (GO:0002021) | 3.19887415 |
| 35 | oxaloacetate metabolic process (GO:0006107) | 3.19273292 |
| 36 | brown fat cell differentiation (GO:0050873) | 3.13981230 |
| 37 | ovulation from ovarian follicle (GO:0001542) | 3.12865253 |
| 38 | fructose metabolic process (GO:0006000) | 3.12834710 |
| 39 | ethanol metabolic process (GO:0006067) | 3.11743837 |
| 40 | adhesion of symbiont to host (GO:0044406) | 3.10549964 |
| 41 | fatty acid homeostasis (GO:0055089) | 3.08285271 |
| 42 | lipid particle organization (GO:0034389) | 3.05726072 |
| 43 | acylglycerol metabolic process (GO:0006639) | 3.03133653 |
| 44 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.02685153 |
| 45 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.02635240 |
| 46 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.01820702 |
| 47 | glomerular filtration (GO:0003094) | 3.01441207 |
| 48 | endocrine hormone secretion (GO:0060986) | 3.01365365 |
| 49 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.00940596 |
| 50 | negative regulation of metanephros development (GO:0072217) | 2.99191311 |
| 51 | neutral lipid metabolic process (GO:0006638) | 2.97151197 |
| 52 | regulation of metalloenzyme activity (GO:0048552) | 2.95062369 |
| 53 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.92988630 |
| 54 | primary alcohol catabolic process (GO:0034310) | 2.92506660 |
| 55 | regulation of gonadotropin secretion (GO:0032276) | 2.92420935 |
| 56 | cellular response to zinc ion (GO:0071294) | 2.91814551 |
| 57 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.91272223 |
| 58 | retinol metabolic process (GO:0042572) | 2.90075550 |
| 59 | membrane raft organization (GO:0031579) | 2.89897425 |
| 60 | regulation of receptor binding (GO:1900120) | 2.89001984 |
| 61 | renal filtration (GO:0097205) | 2.88323995 |
| 62 | negative regulation of protein autophosphorylation (GO:0031953) | 2.88145923 |
| 63 | protein localization to cell surface (GO:0034394) | 2.88091198 |
| 64 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.86922632 |
| 65 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.85708250 |
| 66 | response to nitrosative stress (GO:0051409) | 2.85539520 |
| 67 | cellular response to vitamin (GO:0071295) | 2.85032120 |
| 68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.82016718 |
| 69 | phosphatidic acid biosynthetic process (GO:0006654) | 2.80758293 |
| 70 | phosphatidic acid metabolic process (GO:0046473) | 2.80758293 |
| 71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.80524429 |
| 72 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.80112475 |
| 73 | regulation of lipoprotein metabolic process (GO:0050746) | 2.79769699 |
| 74 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.78866272 |
| 75 | biotin metabolic process (GO:0006768) | 2.77397067 |
| 76 | positive regulation of pseudopodium assembly (GO:0031274) | 2.77339622 |
| 77 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.75692441 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 2.75349267 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.74521493 |
| 80 | negative regulation of amino acid transport (GO:0051956) | 2.71724339 |
| 81 | response to hydroperoxide (GO:0033194) | 2.70582973 |
| 82 | cellular response to lithium ion (GO:0071285) | 2.70207347 |
| 83 | positive regulation of glomerulus development (GO:0090193) | 2.69249237 |
| 84 | type B pancreatic cell proliferation (GO:0044342) | 2.67380607 |
| 85 | fatty acid catabolic process (GO:0009062) | 2.64885625 |
| 86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64722414 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 2.58915564 |
| 88 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.58223241 |
| 89 | xenobiotic catabolic process (GO:0042178) | 2.58162288 |
| 90 | polyketide metabolic process (GO:0030638) | 2.57994059 |
| 91 | doxorubicin metabolic process (GO:0044598) | 2.57994059 |
| 92 | daunorubicin metabolic process (GO:0044597) | 2.57994059 |
| 93 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.57946485 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 2.57405212 |
| 95 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.56669564 |
| 96 | positive regulation of lipid storage (GO:0010884) | 2.55653886 |
| 97 | urea cycle (GO:0000050) | 2.55248075 |
| 98 | glycerol metabolic process (GO:0006071) | 2.54839475 |
| 99 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.53456263 |
| 100 | endothelial cell chemotaxis (GO:0035767) | 2.50353176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.34851649 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.40826752 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.13296431 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.90605654 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.66045448 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.89497149 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.83681337 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.77737562 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46920217 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41414837 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26860916 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.24810126 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.24254325 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11844520 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.11485949 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00867005 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91818817 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88076451 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78974570 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77302702 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75603240 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73844822 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72874993 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71053428 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68989462 |
| 26 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68603911 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66402322 |
| 28 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.61745281 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60142852 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58141314 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.56266521 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55957515 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51772886 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51588907 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49979239 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49695505 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46590050 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46164303 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45524136 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40723474 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39255179 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39255179 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38965641 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36516266 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35663655 |
| 46 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.30588593 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25877952 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23417938 |
| 49 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.22923388 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21707906 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20768851 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17547151 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17297230 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15891667 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15891667 |
| 56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14433914 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14409106 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14090079 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13869493 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10582616 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10041290 |
| 62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08264930 |
| 63 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07736572 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06642533 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06618657 |
| 66 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.05860655 |
| 67 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04162798 |
| 68 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04128311 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03634024 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03534026 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02021743 |
| 72 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02018787 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01840717 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01493621 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01300645 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98869369 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 0.98439716 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96352780 |
| 79 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95240973 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95171068 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94872158 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94716280 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93382332 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93117678 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92944914 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92536397 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91979787 |
| 88 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91431427 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91356777 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90831309 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90513694 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90154764 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89119896 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88929391 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88217458 |
| 96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87687538 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85488806 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85218896 |
| 99 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83981970 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83417682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.39895249 |
| 2 | MP0005666_abnormal_adipose_tissue | 4.28302506 |
| 3 | MP0005360_urolithiasis | 3.41444827 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 3.18552311 |
| 5 | MP0005375_adipose_tissue_phenotype | 3.08118045 |
| 6 | MP0002971_abnormal_brown_adipose | 3.00120574 |
| 7 | MP0005275_abnormal_skin_tensile | 2.67485420 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.55454081 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.53351335 |
| 10 | MP0004130_abnormal_muscle_cell | 2.43077595 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.37386789 |
| 12 | MP0009115_abnormal_fat_cell | 2.30427719 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.27579015 |
| 14 | MP0003011_delayed_dark_adaptation | 2.24889004 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.21814960 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.05690800 |
| 17 | MP0003724_increased_susceptibility_to | 2.03927132 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.97260154 |
| 19 | MP0006138_congestive_heart_failure | 1.88524366 |
| 20 | MP0000751_myopathy | 1.82779299 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.74711359 |
| 22 | MP0004272_abnormal_basement_membrane | 1.74234844 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.73677788 |
| 24 | MP0000003_abnormal_adipose_tissue | 1.73335650 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.72079474 |
| 26 | MP0002970_abnormal_white_adipose | 1.71236539 |
| 27 | MP0005535_abnormal_body_temperature | 1.69347044 |
| 28 | MP0005334_abnormal_fat_pad | 1.68082755 |
| 29 | MP0003828_pulmonary_edema | 1.65953402 |
| 30 | MP0002796_impaired_skin_barrier | 1.63017793 |
| 31 | MP0005365_abnormal_bile_salt | 1.60468263 |
| 32 | MP0009840_abnormal_foam_cell | 1.56892995 |
| 33 | MP0003186_abnormal_redox_activity | 1.56830137 |
| 34 | MP0003959_abnormal_lean_body | 1.54676816 |
| 35 | MP0000343_altered_response_to | 1.49399820 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.48860526 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.47924819 |
| 38 | MP0001958_emphysema | 1.42927515 |
| 39 | MP0003868_abnormal_feces_composition | 1.38463624 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.37582981 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.31676037 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.30346487 |
| 43 | MP0003279_aneurysm | 1.29296356 |
| 44 | MP0005448_abnormal_energy_balance | 1.29001741 |
| 45 | MP0005165_increased_susceptibility_to | 1.25786658 |
| 46 | MP0003075_altered_response_to | 1.24364794 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.24153820 |
| 48 | MP0001879_abnormal_lymphatic_vessel | 1.22534438 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.18090613 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.16373547 |
| 51 | MP0002933_joint_inflammation | 1.15578442 |
| 52 | MP0001764_abnormal_homeostasis | 1.13918930 |
| 53 | MP0000749_muscle_degeneration | 1.13650728 |
| 54 | MP0000249_abnormal_blood_vessel | 1.09106478 |
| 55 | MP0001881_abnormal_mammary_gland | 1.09055178 |
| 56 | MP0005595_abnormal_vascular_smooth | 1.06503200 |
| 57 | MP0005164_abnormal_response_to | 1.06229489 |
| 58 | MP0001661_extended_life_span | 1.06210105 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.01749278 |
| 60 | MP0001542_abnormal_bone_strength | 1.00273137 |
| 61 | MP0003879_abnormal_hair_cell | 0.99558821 |
| 62 | MP0005452_abnormal_adipose_tissue | 0.96867777 |
| 63 | MP0002060_abnormal_skin_morphology | 0.95431995 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 0.94500572 |
| 65 | MP0000858_altered_metastatic_potential | 0.94422212 |
| 66 | MP0000750_abnormal_muscle_regeneration | 0.93103866 |
| 67 | MP0005385_cardiovascular_system_phenoty | 0.92694924 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 0.92694924 |
| 69 | MP0008775_abnormal_heart_ventricle | 0.90538791 |
| 70 | MP0004858_abnormal_nervous_system | 0.90086152 |
| 71 | MP0005023_abnormal_wound_healing | 0.89670174 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88758546 |
| 73 | MP0009379_abnormal_foot_pigmentation | 0.88591715 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.85420260 |
| 75 | MP0000609_abnormal_liver_physiology | 0.84555373 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.84261174 |
| 77 | MP0005166_decreased_susceptibility_to | 0.83809507 |
| 78 | MP0001666_abnormal_nutrient_absorption | 0.83055729 |
| 79 | MP0000230_abnormal_systemic_arterial | 0.81785341 |
| 80 | MP0001756_abnormal_urination | 0.81637953 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.81305593 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.81169907 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.80942344 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.80926117 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 0.80811487 |
| 86 | MP0004087_abnormal_muscle_fiber | 0.78744571 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.78519949 |
| 88 | MP0000759_abnormal_skeletal_muscle | 0.78328287 |
| 89 | MP0002909_abnormal_adrenal_gland | 0.77909861 |
| 90 | MP0005501_abnormal_skin_physiology | 0.76951885 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.73953280 |
| 92 | MP0005330_cardiomyopathy | 0.73949676 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.73663938 |
| 94 | MP0003690_abnormal_glial_cell | 0.73489416 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.72474995 |
| 96 | MP0005409_darkened_coat_color | 0.71117023 |
| 97 | MP0005647_abnormal_sex_gland | 0.70308907 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.68931251 |
| 99 | MP0002972_abnormal_cardiac_muscle | 0.68725584 |
| 100 | MP0000747_muscle_weakness | 0.68483411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acanthosis nigricans (HP:0000956) | 5.71004494 |
| 2 | Hypertriglyceridemia (HP:0002155) | 4.81374918 |
| 3 | Oligomenorrhea (HP:0000876) | 4.64004454 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.96207046 |
| 5 | Axonal loss (HP:0003447) | 3.93748803 |
| 6 | Growth hormone excess (HP:0000845) | 3.83764171 |
| 7 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.80964465 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.74660259 |
| 9 | Complement deficiency (HP:0004431) | 3.57088889 |
| 10 | Abnormality of complement system (HP:0005339) | 3.50381294 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.44686282 |
| 12 | Insulin resistance (HP:0000855) | 3.43113149 |
| 13 | Bone cyst (HP:0012062) | 3.26221246 |
| 14 | Ileus (HP:0002595) | 3.26047870 |
| 15 | Amyloidosis (HP:0011034) | 3.17547928 |
| 16 | Aortic aneurysm (HP:0004942) | 3.12855864 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.07763832 |
| 18 | Pigmentary retinal degeneration (HP:0001146) | 3.01015895 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 2.95425167 |
| 20 | Nausea (HP:0002018) | 2.92565531 |
| 21 | Increased connective tissue (HP:0009025) | 2.87661231 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.85144282 |
| 23 | Malnutrition (HP:0004395) | 2.83216716 |
| 24 | Spinal rigidity (HP:0003306) | 2.80588729 |
| 25 | Hemorrhage of the eye (HP:0011885) | 2.80083512 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.72681652 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72681652 |
| 28 | Glucose intolerance (HP:0000833) | 2.62998850 |
| 29 | Colitis (HP:0002583) | 2.62032940 |
| 30 | Xanthomatosis (HP:0000991) | 2.60877332 |
| 31 | Hydroxyprolinuria (HP:0003080) | 2.58181408 |
| 32 | Abnormality of proline metabolism (HP:0010907) | 2.58181408 |
| 33 | Premature rupture of membranes (HP:0001788) | 2.55249890 |
| 34 | Abnormal glucose tolerance (HP:0001952) | 2.46031693 |
| 35 | Fat malabsorption (HP:0002630) | 2.44260221 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.44013682 |
| 37 | Skin nodule (HP:0200036) | 2.43180528 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 2.40674447 |
| 39 | Myocardial infarction (HP:0001658) | 2.39427937 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.38312433 |
| 41 | Subcapsular cataract (HP:0000523) | 2.38262487 |
| 42 | Neck muscle weakness (HP:0000467) | 2.36080596 |
| 43 | Steatorrhea (HP:0002570) | 2.29659763 |
| 44 | Cervical subluxation (HP:0003308) | 2.27043671 |
| 45 | Glomerulonephritis (HP:0000099) | 2.26250652 |
| 46 | Multiple lipomas (HP:0001012) | 2.24520624 |
| 47 | Bulbar palsy (HP:0001283) | 2.24275391 |
| 48 | Polygenic inheritance (HP:0010982) | 2.20617113 |
| 49 | Hypercortisolism (HP:0001578) | 2.15397552 |
| 50 | Polar cataract (HP:0010696) | 2.15383061 |
| 51 | Wide cranial sutures (HP:0010537) | 2.15325445 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.14584410 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.12707426 |
| 54 | Hyperparathyroidism (HP:0000843) | 2.12050008 |
| 55 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07754711 |
| 56 | Short nail (HP:0001799) | 2.07531023 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03425576 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.01658505 |
| 59 | Joint stiffness (HP:0001387) | 2.00526072 |
| 60 | Wormian bones (HP:0002645) | 2.00518628 |
| 61 | Spinal cord compression (HP:0002176) | 1.97895323 |
| 62 | Thin bony cortex (HP:0002753) | 1.97373013 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 1.96257252 |
| 64 | Vascular tortuosity (HP:0004948) | 1.95597229 |
| 65 | Back pain (HP:0003418) | 1.95005755 |
| 66 | Abnormality of the nasal mucosa (HP:0000433) | 1.94571396 |
| 67 | Lipoatrophy (HP:0100578) | 1.94185147 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 1.93833443 |
| 69 | Nuclear cataract (HP:0100018) | 1.92877505 |
| 70 | Hyporeflexia of lower limbs (HP:0002600) | 1.92593113 |
| 71 | Abnormality of the costochondral junction (HP:0000919) | 1.92493875 |
| 72 | Hypercholesterolemia (HP:0003124) | 1.91702185 |
| 73 | Nephritis (HP:0000123) | 1.88738528 |
| 74 | Abnormal hemoglobin (HP:0011902) | 1.88679935 |
| 75 | Ectopia lentis (HP:0001083) | 1.87105079 |
| 76 | Abnormal eating behavior (HP:0100738) | 1.86591231 |
| 77 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85623500 |
| 78 | Dysostosis multiplex (HP:0000943) | 1.83079993 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 1.82075219 |
| 80 | Epidermoid cyst (HP:0200040) | 1.80790835 |
| 81 | Confusion (HP:0001289) | 1.78113002 |
| 82 | Gastrointestinal dysmotility (HP:0002579) | 1.76705566 |
| 83 | Hypoalphalipoproteinemia (HP:0003233) | 1.75891305 |
| 84 | Foot dorsiflexor weakness (HP:0009027) | 1.75694229 |
| 85 | Increased serum pyruvate (HP:0003542) | 1.75357982 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74053960 |
| 87 | Alopecia of scalp (HP:0002293) | 1.73141458 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72837785 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72454407 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72454407 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72454407 |
| 92 | Emphysema (HP:0002097) | 1.72139649 |
| 93 | Widely patent fontanelles and sutures (HP:0004492) | 1.71764343 |
| 94 | Metaphyseal dysplasia (HP:0100255) | 1.71394937 |
| 95 | Broad metatarsal (HP:0001783) | 1.71381143 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 1.71239425 |
| 97 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.69605829 |
| 98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.69605829 |
| 99 | Shallow orbits (HP:0000586) | 1.68708781 |
| 100 | Rhabdomyolysis (HP:0003201) | 1.68166298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 4.19609443 |
| 2 | MST1R | 3.90939568 |
| 3 | MYLK | 3.43200217 |
| 4 | NME2 | 3.39985722 |
| 5 | ARAF | 3.29627029 |
| 6 | ERN1 | 3.22843136 |
| 7 | EPHA2 | 3.19755460 |
| 8 | EPHB2 | 3.13875954 |
| 9 | RIPK1 | 3.03957156 |
| 10 | TRIB3 | 2.83827882 |
| 11 | DDR2 | 2.61141560 |
| 12 | TGFBR2 | 2.34393879 |
| 13 | PIM2 | 2.17893708 |
| 14 | ABL2 | 2.06001765 |
| 15 | MAPKAPK3 | 2.01145528 |
| 16 | GRK5 | 2.00164970 |
| 17 | TIE1 | 1.97039971 |
| 18 | SIK1 | 1.74572679 |
| 19 | MET | 1.72266793 |
| 20 | TESK2 | 1.62749388 |
| 21 | LIMK1 | 1.53748277 |
| 22 | ILK | 1.41279078 |
| 23 | MOS | 1.41199948 |
| 24 | LATS2 | 1.36556018 |
| 25 | PAK4 | 1.20533782 |
| 26 | MAP3K12 | 1.19459732 |
| 27 | PDGFRA | 1.18296395 |
| 28 | LMTK2 | 1.11800624 |
| 29 | PTK2 | 1.11677839 |
| 30 | PRKAA2 | 1.09540615 |
| 31 | CAMK1D | 1.06101022 |
| 32 | FER | 1.05527676 |
| 33 | PRKG2 | 1.04450470 |
| 34 | MAP3K3 | 1.02285576 |
| 35 | DAPK3 | 1.00170154 |
| 36 | IRAK3 | 0.95616537 |
| 37 | PINK1 | 0.95424382 |
| 38 | TAOK1 | 0.92744504 |
| 39 | LRRK2 | 0.88685387 |
| 40 | SCYL2 | 0.87823100 |
| 41 | MAP3K6 | 0.85965754 |
| 42 | LATS1 | 0.84056849 |
| 43 | MAP3K11 | 0.81113405 |
| 44 | BRAF | 0.80325376 |
| 45 | TBK1 | 0.79983778 |
| 46 | CDC42BPA | 0.79809244 |
| 47 | PRPF4B | 0.79629418 |
| 48 | BMX | 0.74910468 |
| 49 | CAMK1 | 0.74337016 |
| 50 | EEF2K | 0.73154913 |
| 51 | PDPK1 | 0.70093532 |
| 52 | TYK2 | 0.69813248 |
| 53 | PRKD2 | 0.67820121 |
| 54 | EPHB1 | 0.66924581 |
| 55 | TRPM7 | 0.64963727 |
| 56 | ACVR1B | 0.63575633 |
| 57 | CSK | 0.63345186 |
| 58 | MAPK4 | 0.60613521 |
| 59 | NEK9 | 0.60144206 |
| 60 | MAP3K1 | 0.59251104 |
| 61 | PAK1 | 0.57053708 |
| 62 | CAMK2G | 0.56709377 |
| 63 | RIPK4 | 0.56663137 |
| 64 | PTK6 | 0.55931874 |
| 65 | MST4 | 0.55850117 |
| 66 | GSK3A | 0.54668417 |
| 67 | KDR | 0.54136901 |
| 68 | PRKD1 | 0.51489112 |
| 69 | ADRBK1 | 0.51222363 |
| 70 | PAK2 | 0.51209020 |
| 71 | MUSK | 0.50834017 |
| 72 | MAPK12 | 0.49152287 |
| 73 | MAP2K1 | 0.48921095 |
| 74 | MAP3K13 | 0.48892887 |
| 75 | PTK2B | 0.47312645 |
| 76 | VRK2 | 0.46416506 |
| 77 | PRKCI | 0.45463904 |
| 78 | STK38L | 0.45461520 |
| 79 | PKN2 | 0.41888903 |
| 80 | CDK9 | 0.39173142 |
| 81 | PDGFRB | 0.38434833 |
| 82 | AKT3 | 0.38177010 |
| 83 | PRKACG | 0.37569799 |
| 84 | TAOK2 | 0.36179433 |
| 85 | STK38 | 0.35527089 |
| 86 | MAP3K2 | 0.34564925 |
| 87 | ROCK1 | 0.33193422 |
| 88 | MAPKAPK5 | 0.31885011 |
| 89 | PHKG1 | 0.30415290 |
| 90 | PHKG2 | 0.30415290 |
| 91 | AKT2 | 0.29488939 |
| 92 | DMPK | 0.29420257 |
| 93 | BCKDK | 0.27332007 |
| 94 | IGF1R | 0.26673555 |
| 95 | PRKG1 | 0.25189806 |
| 96 | ICK | 0.25095537 |
| 97 | MTOR | 0.24388877 |
| 98 | MAPK7 | 0.22996700 |
| 99 | HIPK2 | 0.22839461 |
| 100 | CDK6 | 0.22514329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.83182487 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.21815297 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.20906753 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.05829733 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.89350459 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.63564595 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.62713666 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.36748395 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.30772337 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.27456854 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.25508887 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21048115 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.08805605 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05368008 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.99664453 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.98208879 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.96432995 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91199869 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85374742 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81393968 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62054772 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58593706 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55576859 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53363437 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.45325691 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44018439 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43684052 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41888378 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37009535 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34941008 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34111754 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32531782 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31625647 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31406848 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28830808 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20739879 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18379100 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17214991 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15215163 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.12047997 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10694888 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08797046 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04771504 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99749688 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99468729 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90973104 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90043242 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87792315 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87480069 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87122413 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85216698 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80959198 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79463295 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.78701215 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.74195337 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.73269101 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70443909 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69632971 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.65658728 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.65507821 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63674247 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63582707 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62858351 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61442123 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58355441 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57447452 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55709785 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.53299182 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48039124 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.46330270 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45289476 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43328934 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40655847 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38619385 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37808782 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37405285 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33132638 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29468137 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28490911 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27303618 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.26223585 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25872766 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25357964 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23635473 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.22499745 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22478043 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.21257639 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.21252363 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21129040 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.20630110 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19857910 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18374330 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.17539924 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.16294786 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14986670 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.14814352 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.14491779 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.13065721 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12315540 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11948395 |

